510(k) K770453

PHOSPHATASE PROCEDURE, TEKPOINT ALKALINE by Icn Pharmaceuticals, Inc. — Product Code CIO

K770453 is an FDA 510(k) premarket notification submitted by Icn Pharmaceuticals, Inc. for the device "PHOSPHATASE PROCEDURE, TEKPOINT ALKALINE". The FDA issued a decision of Substantially Equivalent on May 3, 1977. The device falls under product code CIO (Thymolphthalein Monophosphate, Alkaline Phosphatase Or Isoenzymes), a Class II device regulated under 21 CFR 862.1050. Icn Pharmaceuticals, Inc. has 29 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
May 3, 1977
Date Received
Mar 8, 1977
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Thymolphthalein Monophosphate, Alkaline Phosphatase Or Isoenzymes
Device Class
Class II
Regulation Number
862.1050
Review Panel
CH
Submission Type
510(k)

Need the full FDA record for Icn Pharmaceuticals, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K770453. Report a data issue: hello@regdatalab.com.